Previous studies also showed that anti‐TNF leads to decreased T‐cell activation, as demonstrated by variation of CD25 expression, in IBD 22, 23, ulcerative colitis 24, psoriasis 23, and RA 25, while the effect on CD69 was more variable 23, 25. The gene discussed is CD69; the disease is psoriasis.